Reverse transcriptase-progress, problems and prospects.
D000818:Animals; D001358:Avian Sarcoma Viruses / Q000201:enzymology; D002455:Cell Division; D003588:Cytopathogenic Effect, Viral; D004247:DNA / Q000096:biosynthesis; D004254:DNA Nucleotidyltransferases / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D006801:Humans; D008324:Mammary Tumor Virus, Mouse / Q000201:enzymology; D009693:Nucleic Acid Hybridization; D009858:Oncogenic Viruses / Q000201:enzymology*; D012313:RNA / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D012367:RNA, Viral; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D011925:Rauscher Virus / Q000201:enzymology; D012260:Ribonucleases / Q000378:metabolism; D012293:Rifampin / Q000494:pharmacology
D012367:RNA, Viral; D012313:RNA; D004247:DNA; D012343:RNA, Transfer; D004254:DNA Nucleotidyltransferases; D012194:RNA-Directed DNA Polymerase; D012321:DNA-Directed RNA Polymerases; D012260:Ribonucleases; D012293:Rifampin